0001127602-20-027459.txt : 20201023
0001127602-20-027459.hdr.sgml : 20201023
20201023163231
ACCESSION NUMBER: 0001127602-20-027459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201021
FILED AS OF DATE: 20201023
DATE AS OF CHANGE: 20201023
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENDERSON LORI M.
CENTRAL INDEX KEY: 0001221127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 201258070
MAIL ADDRESS:
STREET 1: MOLDFLOW CORP
STREET 2: 430 BOSTON POST ROAD
CITY: WAYLAND
STATE: MA
ZIP: 01778
FORMER NAME:
FORMER CONFORMED NAME: HENDERSON LORI M
DATE OF NAME CHANGE: 20030228
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-10-21
0001682852
Moderna, Inc.
MRNA
0001221127
HENDERSON LORI M.
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
General Counsel and Secretary
Common Stock
2020-10-21
4
M
0
32000
14.85
A
32681
D
Common Stock
2020-10-21
4
S
0
1697
68.70
D
30984
D
Common Stock
2020-10-21
4
S
0
14148
69.84
D
16836
D
Common Stock
2020-10-21
4
S
0
15455
70.56
D
1381
D
Common Stock
2020-10-21
4
S
0
700
71.39
D
681
D
Stock Option (Right to Buy)
14.85
2020-10-21
4
M
0
32000
0
D
2028-06-26
Common Stock
32000
367522
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2020.
Includes 681 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 29, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.20 to $69.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.25 to $70.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.27 to $71.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.34 to $71.45. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.
/s/ Lori Henderson
2020-10-23